Ganoderma lucidum ('Lingzhi'); acute and short-term biomarker response to supplementation

International Journal of Food Sciences and Nutrition

Volumn 55, Issue 1, 2004, Pages 75-83

  Wachtel Galor, Sissi ^a   Szeto, Yim Tong ^a   Tomlinson, Brian ^b   Benzie, Iris F F ^a  

^a HONG KONG POLYTECHNIC UNIVERSITY   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; BIOLOGICAL MARKER; DNA; GANODERMA LUCIDUM EXTRACT; GLUTATHIONE PEROXIDASE; LIPID; PLACEBO; SUPEROXIDE DISMUTASE; URIC ACID;

ADULT; ANTIOXIDANT ACTIVITY; AQUEOUS SOLUTION; ARTICLE; BLOOD ANALYSIS; CARDIOVASCULAR RISK; CHINESE HERB; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET RESTRICTION; DIET SUPPLEMENTATION; DNA DAMAGE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG ABSORPTION; DRUG DISTRIBUTION; ENZYME ACTIVITY; ERYTHROCYTE; FEMALE; FOOD INTAKE; GANODERMA LUCIDUM; HUMAN; HUMAN EXPERIMENT; IN VITRO STUDY; ISCHEMIC HEART DISEASE; MALE; NORMAL HUMAN; RISK ASSESSMENT; TIME; URINALYSIS; VOLUNTEER;

GANODERMA LUCIDUM;

EID: 0942277178     PISSN: 09637486     EISSN: None     Source Type: Journal    
DOI: 10.1080/09637480310001642510     Document Type: Article

References (41)

1. Benzie IFF & Strain JJ (1996a): The ferric reducing ability of plasma (FRAP) as a measure of 'antioxidant power': The FRAP assay. Anal Biochem. 239, 70-76.
2. Benzie IFF & Strain JJ (1996b): Uric acid Friend or Foe? Redox Rep. 2(4), 231-234.
3. Benzie IFF & Strain JJ (1997): Simultaneous automated measurement of total 'antioxidant' (reducing) capacity and ascorbic acid concentrations. Redox Rep. 3, 233-238.
4. Benzie IFF, Strain JJ (1999): Ferric reducing/antioxidant power assay: direct measure of total antioxidant activity of biological fluids and modified version for stimultaneous measurment of total antioxidant power and ascorbic acid concentrations. In Methods in Enzymology: Oxidants and Antioxidants Part A. 1st ed., Packer L, ed. 299, 15-27. London: Academic Press Ltd.
5. Benzie IFF & Szeto YT (1999): Total antioxidant capacity of teas by the ferric reducing/antioxidant power (FRAP) assay. J Agric Food Chem. 47(2), 633-636.
6. Benzie IFF, Szeto YT, Strain JJ & Tomlinson B (1999): Consumption of green tea causes rapid increase in plasma antioxidant power in humans. Nutr Cancer. 34(1), 83-87.
7. Borchers AT, Stern JS, Hackman RM, Keen CL & Gershwin ME (1999): Minireview: mushrooms, tumors and immunity. Proc Soc Exp Biol Med. 221(4), 281-293.
8. Brandt RB, Kaugars GE, Riley WT, Bei RA, Silverman S, Lovas JGL, Dezzutti BP & Chan W (1996): Evaluation of serum and tissue levels of α-tocopherol. Biochem Molecular Med. 57, 64-66.
9. Chang R (1994): Effective dose of Ganoderma in humans. Proceedings of Contributed Symposium, 5th International Mycological Congress, Vancouver, 14-21 August. 59 (A, B) 117-121. Vancouver, Canada.
10. Chang ST & Buswell JA (1999): Ganoderma lucidum (Curt.:Fr.) P. Karst. (Aphyllophoromycetideae) - A Mushrooming Medicinal Mushroom. Int J Med Mushrooms. 1, 139-146.
11. Chen AW, Miles PG (1996): Biomedical research and the application of mushroom nutriceuticals from Ganoderma lucidum. Royse DJ, ed. In Mushroom Biology and Mushroom Products. p. 161-175. University Park, PA: Penn State University.
12. Chirico S, Smith C, Marchant C, Mitchinson MJ & Halliwell B (1993): Lipid peroxidation in hyperlipidaemic patients. A study of plasma using an HPLC-based thiobarbituric acid test. Free Rad Res Comms. 19, 51-7.
13. Chiu SW, Wang ZM, Leung TM & Moore D (2000): Nutritional value of Ganoderma extract and assessment of its genotoxicity and antigenotoxicity using comet assays of mouse lymphocytes. Food Chem Toxicol. 38, 173-178.
14. Collins AR, Dusinska M, Franklin M, Somorovska M, Petrovska H, Duthie S, Fillion L, Panayiotidis M, Raslova K & Vaughan N (1997): Comet assay in human biomonitoring studies: reliability, validation, and applications. Environ Mol Mutagen. 30, 139-146.
15. Freedman DS, Williamson DF, Gunter EW & Byers T (1995): Relation of serum uric acid to mortality and ischemic heart disease. The NHANES I epidemiologic follow-up study. Am J Epidemiol. 141(7), 637-644.
16. Friedewald WT, Levy RI & Fredrickson DS (1972): Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 18(6), 499-502.
17. Furusawa E, Chou SC, Furusawa S, Hirazumi A & Dang Y (1992): Antitumour activity of Ganoderma lucidum, an edible mushroom, on intraperitoneally implanted Lewis lung carcinoma in synergenic mice. Phytother Res. 6, 300-304.
18. Haralampidis K, Trojanowska M & Osbourn AE (2002): Biosynthesis of triterpenoid saponins in plants. Adv Biochem Eng Biotechnol. 75, 31-49.
19. Jentzsch AM, Bachmann H, Furst P & Biesalski HK (1996): Improved analysis of malondoaldehyde in human body fluids. Free Rad Biol Med. 20, 251-256.
20. Jong SC & Birmingham JM (1992): Medicinal benefits of the mushroom Ganoderma. Adv App Microbiol. 37, 101-134.
21. Khaw KT, Bingham S, Welch A, Luben R, Wareham N, Oakes S & Day N (2001): Relation between plasma ascorbic acid and mortality in men and women in EPIC-Norfolk prospective study: a prospective population study. European Prospective Investigation into Cancer and Nutrition. Lancet. 357, 657-663.
22. Kim HS, Kacew S & Lee BM (1999): In vitro chemopreventive effects of plant polysaccharides (Aloe Barbadensis miller, Lentinus endodes, Ganoderma lucidum and Coriolus versicolor). Carcinogenesis. 20, 1637-1640.
23. Komoda Y, Shimizu M, Sonoda Y & Sato Y (1989): Ganoderic acid and its derivatives as cholesterol synthesis inhibitors. Chem Pharm Bull. 37(2), 531-533.
24. Lee JM, Kwon H, Jeong H, Lee JW, Lee SY, Baek SJ & Surh YJ (2001): Inhibition of lipid peroxidation and oxidative DNA damage by Ganoderma lucidum. Phytother Res. 15, 245-249.
25. Lee SY & Rhee HM (1990): Cardiovascular effects of mycelium extract of Ganoderma lucidum: Inhibition of sympathetic outflow as a mechanism of its hypotensive action. Chem Pharm Bull. 38(5), 1359-1364.
26. Lopes-Virella MF, Stone P, Ellis S & Colwell JA (1977): Cholesterol determination in high-density lipoproteins separated by three different methods. Clin Chem. 23(5), 882-884.
27. Manzoni M & Rollini M (2002): Biosynthesis and biotechnological production of statins by filamentous fungi and application of these cholesterol-lowering drugs. Appl Microbiol Biotechnol. 58, 555-564.
28. Mashour NK, Lin GI & Frishman WH (1998): Herbal medicine for the treatment of cardiovascular disease: clinical considerations. Arch Intern Med. 158, 2225-2234.
29. Min BS, Gao JJ, Nakamura N & Hattori M (2000): Triterpenes from the spores of Ganoderma lucidum and their cytotoxicity against Meth-A and LLC Tumor Cells. Chem Pharm Bull 48(7), 1026-1033.
30. Mizuno T, Wang G, Zhang J, Kawagishi H, Nishitoba T & Li J (1995): Reishi, Ganoderma lucidum and Ganoderma tsugae: bioactive substances and medicinal effects. Food Rev Int 11(1), 151-166.
31. Shiao MS, Lee KR, Lin LJ & Wang CT (1994): Natural products and biological activities of the Chinese medicinal fungus Ganoderma lucidum. American Chemical Society Symposium Series. 547, 342-354.
32. Soo TS (1996): Effective dosage of the extract of Ganoderma lucidum in the treatment of various ailments. Royse DJ, ed. In Mushroom Biology and Mushroom Products. p. 177-185. University Park, PA: Penn State University.
33. Szeto YT & Benzie IFF (2002): Effects of dietary antioxidants on human DNA ex vivo. Free Rad Res. 36(1), 113-118.
34. Szeto YT, Tomlinson B & Benzie IFF (2002): Total antioxidant and ascorbic acid content of fresh fruits and vegetables: implications for dietary planning and food preservation. British J Nut. 87, 55-59.
35. Thurnham DI, Davies JA, Crump BJ, Situnayake RD & Davis M (1986): The use of different lipids to express serum tocopherol: lipid ratios for the measurment of vitamin E status. Ann Clin Biochem. 23, 514-520.
36. Traber MG (2001): Does vitamin E decrease heart attack risk? Summary and implications with respect to dietary recommendations. J Nutr. 131, 395S-397S.
37. Verdecchia P, Schillaci G, Reboldi G, Santeusanio F, Porcellati C & Brunetti P (2000): Relation between serum uric acid and risk of cardiovascular disease in essential hypertension, the PIUMA study. Hypertension. 36, 1072-1078.
38. Wang SY, Hsu ML, Hsu HC, Tzeng CH, Lee SS, Shiao MS & Ho CK (1997): The anti-tumor effect of Ganoderma lucidum is mediated by cytokines released from activated macrophages and T lymphocytes. Int J Cancer. 70(6), 699-705.
39. Wasser SP & Weis AL (1999): Medicinal properties of substances occuring in higher basidiomycetes mushrooms: current perspectives (Review). Int J Med Mushrooms, 1, 31-62.
40. Willard T (1990): Reishi Mushroom, herb of spiritual potency and medical wonder. Sylvan Press, Washington.
41. Zhu M, Chang Q, Wong LK, Chong FS & Li RC (1999): Triterpene Antioxidants from Ganoderma lucidum. Phytother Res. 13, 529-531.